Post Content
Viking Therapeutics Inc. (NASDAQ:VKTX) is one of the
20 Stocks Jim Cramer Wanted You To Sell & Immediately Get Out Of. Viking Therapeutics Inc. (NASDAQ:VKTX) is a biotechnology company developing drugs for ailments such as anemia and non-alcoholic steatohepatitis. Its shares are up by 49% over the past year and are down by 2.4% year-to-date. Several catalysts appear to have affected Viking Therapeutics Inc. (NASDAQ:VKTX)’s shares since Cramer discussed them in January 2025. One major event occurred on August 19th when the stock dipped by an unbelievable 42%. On that day, the firm reported the latest results for its VK-2735 drug that aims to work with the weight loss GIP and GLP-1 receptors. The drug’s mid-stage trial saw participants lose 12% of their body weight, while, according to media reports, investors were aiming for higher results. Since the dip in August, Viking Therapeutics Inc. (NASDAQ:VKTX)’s shares are up by 41%. Here is what Cramer said about the firm on Mad Money:
Copyright: iggyphoto / 123RF Stock Photo
“I want you to sell Viking Therapeutics and roll it into Viking Holdings, which is a fantastic cruise line, does not save lives, does not lower your blood pressure… but darn, you’ll have a good time.”
While we acknowledge the potential of VKTX as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
READ NEXT: 33 Stocks That Should Double in 3 Years and Cathie Wood 2026 Portfolio: 10 Best Stocks to Buy.
Disclosure: None. Follow Insider Monkey on Google News.